Efficacy of Stiripentol Beyond Dravet Syndrome: A Retrospective Medical Record Review of Patients with Drug-Resistant Epilepsies
Abstract Introduction Stiripentol is approved as an add-on therapy with clobazam and/or valproate for seizures associated with Dravet syndrome (DS). Evidence of stiripentol efficacy in other drug-resistant epilepsies is limited. Methods This was a single-centre, retrospective, observational study of...
Saved in:
| Main Authors: | Víctor Soto-Insuga, Elena González-Alguacil, María Ballarà-Petitbò, Nuria Lamagrande-Casanova, Anna Duat-Rodríguez, Cristina Benítez-Provedo, Elena Cardenal-Muñoz, Juan José García-Peñas |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2025-05-01
|
| Series: | Neurology and Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s40120-025-00755-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genetics and clinical correlation of Dravet syndrome and its mimics – experience of a tertiary center in Taiwan
by: Yi-Hsuan Liu, et al.
Published: (2021-09-01) -
Phenotypes of Dravet Syndrome
by: Rebecca Garcia-Sosa, et al.
Published: (2016-08-01) -
EVALUATION OF CLINICAL, DEMOGRAPHIC AND ELECTROENCEPHALOGRAPHY FINDINGS OF DRAVET SYNDROME PATIENTS
by: Mahmut Aslan, et al.
Published: (2021-01-01) -
Atypical course of severe myoclonic epilepsy of infancy (Dravet syndrome)
by: B. A. Abusueva, et al.
Published: (2024-07-01) -
Communicating a diagnosis of Dravet syndrome to parents/caregivers: An international Delphi consensus
by: Andreas Brunklaus, et al.
Published: (2025-04-01)